GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Taiwan Bio Therapeutics Co Ltd (ROCO:6892) » Definitions » Price-to-Tangible-Book

Taiwan Bio Therapeutics Co (ROCO:6892) Price-to-Tangible-Book : 4.28 (As of Jun. 05, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Taiwan Bio Therapeutics Co Price-to-Tangible-Book?

As of today (2024-06-05), Taiwan Bio Therapeutics Co's share price is NT$37.80. Taiwan Bio Therapeutics Co's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was NT$8.82. Hence, Taiwan Bio Therapeutics Co's Price to Tangible Book Ratio of today is 4.28.

The historical rank and industry rank for Taiwan Bio Therapeutics Co's Price-to-Tangible-Book or its related term are showing as below:

ROCO:6892' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.13   Med: 3.49   Max: 4.34
Current: 4.29

During the past 5 years, Taiwan Bio Therapeutics Co's highest Price to Tangible Book Ratio was 4.34. The lowest was 3.13. And the median was 3.49.

ROCO:6892's Price-to-Tangible-Book is ranked worse than
66.83% of 1221 companies
in the Biotechnology industry
Industry Median: 2.78 vs ROCO:6892: 4.29

A closely related ratio is called PB Ratio. As of today, Taiwan Bio Therapeutics Co's share price is NT$37.80. Taiwan Bio Therapeutics Co's Book Value per Sharefor the quarter that ended in Dec. 2023 was NT$9.85. Hence, Taiwan Bio Therapeutics Co's P/B Ratio of today is 3.84.


Taiwan Bio Therapeutics Co Price-to-Tangible-Book Historical Data

The historical data trend for Taiwan Bio Therapeutics Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiwan Bio Therapeutics Co Price-to-Tangible-Book Chart

Taiwan Bio Therapeutics Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
- - - 3.13 3.84

Taiwan Bio Therapeutics Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial - - 3.13 3.33 3.84

Competitive Comparison of Taiwan Bio Therapeutics Co's Price-to-Tangible-Book

For the Biotechnology subindustry, Taiwan Bio Therapeutics Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taiwan Bio Therapeutics Co's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Taiwan Bio Therapeutics Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Taiwan Bio Therapeutics Co's Price-to-Tangible-Book falls into.



Taiwan Bio Therapeutics Co Price-to-Tangible-Book Calculation

Taiwan Bio Therapeutics Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=37.80/8.822
=4.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Taiwan Bio Therapeutics Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Taiwan Bio Therapeutics Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Taiwan Bio Therapeutics Co (ROCO:6892) Business Description

Traded in Other Exchanges
N/A
Address
No. 18, Lane 120, Hu Road, Section 1, 6th Floor, Neihu District, Taipei, TWN
Taiwan Bio Therapeutics Co Ltd is a regenerative medicine company specializing in the development of new cell medicines. It provides cell product process development and foundry (CDMO/CMO) services.

Taiwan Bio Therapeutics Co (ROCO:6892) Headlines

No Headlines